tradingkey.logo

Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology

ReutersDec 15, 2025 12:19 PM

- Cencora Inc COR.N:

  • CENCORA OUTLOOK FY ADJUSTED EPS USD 17.45-17.75

  • CENCORA - TO BUY MAJORITY STAKE IN ONEONCOLOGY

  • CENCORA - ONEONCOLOGY VALUED AT $7.4 BILLION IN DEAL

  • CENCORA - TO BUY STAKE IN ONEONCOLOGY FOR $3.6 BILLION

  • CENCORA - TO FUND DEAL WITH NEW DEBT FINANCING

  • CENCORA - RAISES LONG-TERM GUIDANCE FOR ADJUSTED OPERATING INCOME AND ADJUSTED EPS

  • CENCORA - EXPECTS DEAL TO BE ABOUT NEUTRAL, NET OF FINANCING COSTS, TO CO'S ADJUSTED DILUTED EPS IN FIRST TWELVE MONTHS FOLLOWING CLOSE

  • CENCORA OUTLOOK LONG-TERM ADJUSTED OPERATING INCOME 7% TO 10%

  • CENCORA - IN ANTICIPATION OF COMPANY'S ACQUISITION OF ONEONCOLOGY, IT IS PAUSING SHARE REPURCHASES

  • CENCORA - MORE LIKELY COMPANY'S FULL YEAR ADJUSTED DILUTED EPS WILL BE TOWARDS LOWER HALF OF ITS GUIDANCE RANGE OF $17.45 TO $17.75

  • CENCORA - SEES LONG-TERM ADJUSTED DILUTED EARNINGS PER SHARE UP 10% TO 14%

  • CENCORA - REITERATES FISCAL 2026 GUIDANCE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI